AXSOME THERAPEUTICS, INC. Debt Conversion, Converted Instrument, Amount
AXSOME THERAPEUTICS, INC. (AXSM) reported Debt Conversion, Converted Instrument, Amount of $15.30 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2018-03-07
- AXSOME THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2015 was $15.30M, a 244.36% increase from fiscal 2014.
- AXSOME THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2014 was $4.44M.
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2015-12-31 | $15.30M 10-K · filed 2018-03-07 |
| 2014-12-31 | $4.44M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |